The Food and Drug Administration announced Thursday that at least one person has died after a fecal microbiome transplant transmitted drug-resistant bacteria.
The FDA said one other person was also sick from the transplant; both people had weaker-than-normal immune systems and received stool from the same donor. The stool was not tested for a type of bacteria that produces an enzyme called beta-lactamase.
The agency did not disclose the location of the people and the name of the company or group that provided the stool.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect